Даниэль Шуваль

Научные публикации

• Recurrence rates following ileo-colic resection in pediatric patients with Crohn's disease
• A somatic hypermutation-based machine learning model stratifies individuals with Crohn's disease and controls
• Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency
• RIPK1 mutations causing infantile-onset IBD with inflammatory and fistulizing features
• Incidence, Management, and Outcomes of Very Early Onset Inflammatory Bowel Diseases and Infantile-Onset Disease: An Epi-IIRN Study
• Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
• Practice Variations in the Management of Infants With Non-IgE-Mediated Cow's Milk Protein Allergy
• Glycogen Storage Disease type IA refractory to cornstarch: Can next generation sequencing offer a solution?
• Mucosal healing with methotrexate versus azathioprine treatment in pediatric Crohn's disease as reflected by fecal calprotectin
• Mucus sialylation determines intestinal host-commensal homeostasis
• Host transcriptome signatures in human faecal-washes predict histological remission in patients with IBD
• Neonatal inflammatory skin and bowel disease type 1 caused by a complex genetic defect and responsive to combined anti-tumour necrosis factor-α and interleukin-12/23 blockade
• α4β7 expression guides B cells to front lines of defense in the gut
• Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern
• An Integrated Taxonomy for Monogenic Inflammatory Bowel Disease
• Clinical Features and Outcomes of Paediatric Patients With Isolated Colonic Crohn Disease
• Motivational disposition towards psychological characteristics of israeli children with inflammatory bowel diseases: A case-control study
• High anti-TNFα Concentrations Are Not Associated With More Adverse Events in Pediatric Inflammatory Bowel Disease
• CD16+CD163+ monocytes traffic to sites of inflammation during necrotizing enterocolitis in premature infants
• Monitoring Enables Progress: A Nationwide Quality Improvement Program in Children With Crohn Disease
• EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients
• T and B Cell Receptor Immune Repertoire Analysis using Next-generation Sequencing
• Mucosal IL-10 and IL-10 receptor expression patterns in paediatric patients with ulcerative colitis
• Clinical Genomics for the Diagnosis of Monogenic Forms of Inflammatory Bowel Disease: A Position Paper From the Paediatric IBD Porto Group of European Society of Paediatric Gastroenterology, Hepatology and Nutrition
• Heat Shock Factor 1-dependent extracellular matrix remodeling mediates the transition from chronic intestinal inflammation to colon cancer
• Distinct extracellular-matrix remodeling events precede symptoms of inflammation
• Trabecular Bone Score in Children and Adolescents With Inflammatory Bowel Diseases
• Enhanced Collagen Deposition in the Duodenum of Patients with Hyaline Fibromatosis Syndrome and Protein Losing Enteropathy
• Circulating α4β7⁺ Memory T Cells in Pediatric IBD Patients Express a Polyclonal T Cell Receptor Repertoire
• The History of Hepatitis A
• The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update
• Monogenic Inflammatory Bowel Disease: It's Never Too Late to Make a Diagnosis
• In utero human intestine harbors unique metabolome, including bacterial metabolites
• The case for simplifying and using absolute targets for viral hepatitis elimination goals
• Gastrointestinal Hemorrhage: A Manifestation of the Telomere Biology Disorders
• Predictive Prenatal Diagnosis for Infantile-onset Inflammatory Bowel Disease Because of Interleukin-10 Signalling Defects
• Antibodies Against Glycoprotein 2 Are Specific Biomarkers for Pediatric Crohn's Disease
• Evaluation of very early-onset inflammatory bowel disease
• Infliximab in young paediatric IBD patients: it is all about the dosing
• An RTEL1 Mutation Links to Infantile-Onset Ulcerative Colitis and Severe Immunodeficiency
• Therapeutic Drug Monitoring-guided High-dose Infliximab for Infantile-onset Inflammatory Bowel Disease: A Case Series
• APPROACH TO VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE
• Alterations in T and B Cell Receptor Repertoires Patterns in Patients With IL10 Signaling Defects and History of Infantile-Onset IBD
• Knowledge of disease and self-management of adolescents with inflammatory bowel diseases
• Very Early Onset Inflammatory Bowel Disease: A Clinical Approach With a Focus on the Role of Genetics and Underlying Immune Deficiencies
• POSITION PAPER: ANTI-TNFα DRUG AND ANTI-DRUG MONITORING IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE
• Defining the Celiac Disease Transcriptome using Clinical Pathology Specimens Reveals Biologic Pathways and Supports Diagnosis
• Humanized mouse models of genetic immune disorders and hematological malignancies
• Maturation of the Human Intestinal Immune System Occurs Early in Fetal Development
• Longitudinal changes in bone mineral density in children with inflammatory bowel diseases